Back to STATE STREET CORP STATE STREET CORP

CADLCADL
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in CANDEL THERAPEUTICS INC

STATE STREET CORP holds 3.5M shares of CADL (CANDEL THERAPEUTICS INC), worth $36.6M as of 2026-Q2. The position was increased (+333.7% shares). CADL represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$36.6M

Current Shares

3.5M

Total Value Change

+$36.5M

Total Shares Change

+3.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
3.5M
+333.7%
$36.6M0.0%$10.30
47
2026-Q1
Increased
818,558
+3.3%
$4M0.0%$4.91
28
2025-Q4
Increased
792,218
+15.0%
$4.5M0.0%$5.71
31
2025-Q3
Increased
688,766
+5.6%
$3.5M0.0%$5.40
28
2025-Q2
Increased
651,979
+15.7%
$3.3M0.0%$4.90
31
2025-Q1
Increased
563,404
+0.4%
$3.2M0.0%$5.95
26
2024-Q4
Increased
560,969
+14.0%
$4.9M0.0%$7.95
31
2024-Q3
Increased
492,005
+4.1%
$3.4M0.0%$7.21
28
2024-Q2
Increased
472,798
+1613.0%
$2.9M0.0%$6.20
42
2024-Q1
Unchanged
27,600
0.0%
$43,6080.0%$1.58
0
2023-Q4
New
27,600
-
$40,5720.0%$1.47
31

Other major holders of CADL: FMR LLC, RTW INVESTMENTS, LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used